Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-07
2005-06-07
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S281000
Reexamination Certificate
active
06903106
ABSTRACT:
Polymorph Form III of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide, and use thereof as a sedative-hypnotic, anxiolytic, anticonvulsant, and/or skeletal muscle relaxant agent. Related compositions and methods are also disclosed, particularly with regard to treatment of insomnia.
REFERENCES:
patent: 6384221 (2002-05-01), Thiele et al.
patent: 6399621 (2002-06-01), Dusza et al.
patent: 6472528 (2002-10-01), Gross et al.
patent: 6485746 (2002-11-01), Campbell et al.
patent: 6544999 (2003-04-01), Thiele et al.
patent: 2002/0107256 (2002-08-01), Thiele et al.
DuBois, III Henry R.
Hettinger Donald
Zook Scott E.
McKenzie Thomas C.
Neurocrine Biosciences Inc.
Seed IP Law Group PLLC
LandOfFree
Polymorph of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorph of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorph of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3484568